Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical and Biomedical Analysis|April 30, 2023
In-vitro metabolism of LXY18, an orally available, potent blocker of AURKB relocation in mitosisJinhua Li, Namrta Choudhry, Gang Lv, et al.
Journal of Natural Products|August 18, 2021
The Phytochemical Scoulerine Inhibits Aurora Kinase Activity to Induce Mitotic and Cytokinetic DefectsJinhua Li, Ziqi Yan, Hongmei Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 22, 2018
Dihydroartemisinin ameliorates sepsis-induced hyperpermeability of glomerular endothelium via up-regulation of occludin expressionZuowang Cheng, Ruixia Qi, Liqun Li, et al.
Cancer Biology & Therapy|December 9, 2014
Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesisFengyun Dong, Xia Zhou, Changsheng Li, et al.
Plos One|October 30, 2023
The Aurora kinase B relocation blocker LXY18 triggers mitotic catastrophe selectively in malignant cellsJulia Kalashova, Chenglu Yang, Hongmei Li, et al.
Circulation Research|January 13, 2021
Aberrant Activation of Notch1 Signaling in Glomerular Endothelium Induces AlbuminuriaLiqun Li, Qiang Liu, Tongyao Shang, et al.
Experimental and Therapeutic Medicine|December 8, 2015
Plasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarctionYan Li, Liqun Li, Fengyun Dong, et al.
Oncotarget|January 5, 2018
GATA3-induced vWF upregulation in the lung adenocarcinoma vasculatureYinghua Xu, Silin Pan, Jing Liu, et al.
ACS Pharmacology & Translational Science|August 17, 2023
Orally Bioavailable 4-Phenoxy-quinoline Compound as a Potent Aurora Kinase B Relocation Blocker for Cancer TreatmentJinhua Li, Ting Zhang, Qiong Shi, et al.
Pageof 3